(Q39391018)

11 September 2017

title

BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro (English)

1 reference

11 September 2017

1 reference

Jin Bai

1

1 reference

11 September 2017

Peng-Jin Mei

2

1 reference

11 September 2017

Hui Liu

3

1 reference

11 September 2017

Chen Li

4

1 reference

11 September 2017

Wang Li

5

1 reference

11 September 2017

Yong-Ping Wu

6

1 reference

11 September 2017

Zheng-Quan Yu

7

1 reference

11 September 2017

Jun-Nian Zheng

8

1 reference

11 September 2017

publication date

24 February 2012

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

published in

1 reference

11 September 2017

volume

138

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

991-998

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-012-1172-8

11 September 2017

exact match

0 references

cites work

Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis

1 reference

12 December 2020

The SWI/SNF complex and cancer

1 reference

12 December 2020

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

1 reference

12 December 2020

The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a

1 reference

12 December 2020

Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies

1 reference

12 December 2020

RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration

1 reference

12 December 2020

Expression of BRG1, a human SWI/SNF component, affects the organisation of actin filaments through the RhoA signalling pathway.

1 reference

12 December 2020

BRG1 expression is increased in human cutaneous melanoma

1 reference

12 December 2020

Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme.

1 reference

12 December 2020

Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors

1 reference

12 December 2020

BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines

1 reference

12 December 2020

BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI.

1 reference

12 December 2020

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

12 December 2020

Chromatin structure and DNA damage repair

1 reference

12 December 2020

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.

1 reference

12 December 2020

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

12 December 2020

Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation

1 reference

12 December 2020

JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling

1 reference

12 December 2020

Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma

1 reference

12 December 2020

Role for BRG1 in cell cycle control and tumor suppression

1 reference

12 December 2020

The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.

1 reference

12 December 2020

Mutants of yeast defective in sucrose utilization.

1 reference

12 December 2020

Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers

1 reference

12 December 2020

Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas

1 reference

12 December 2020

Therapeutic targets in malignant glioblastoma microenvironment

1 reference

12 December 2020

Diversity and specialization of mammalian SWI/SNF complexes

1 reference

12 December 2020

Regulators of G1 cyclin-dependent kinases and cancers

1 reference

12 December 2020

Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.

1 reference

12 December 2020

Epidemiology and etiology of gliomas

1 reference

12 December 2020

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

SWI/SNF: the crossroads where extracellular signaling pathways meet chromatin.

1 reference

12 December 2020

Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.

1 reference

12 December 2020

10.1007/S00432-012-1172-8

Identifiers

DOI

1 reference

11 September 2017

1 reference